Trevena
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, Trevena sits in the top decile of US sponsors by registered trial count (#934 of 15,742 sponsors by registered trial count).
Trevena: 15 sponsored US clinical trials, none currently recruiting.
Trevena sponsors 15 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 14 completed. 3 of these trials are in Phase 3-4 (later-stage) and 12 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Kidney Disease, with 1 trials.
Top-decile sponsor footprint
Trevena ranks in the top decile of sponsors by registered trial count (#934 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
14 of 15 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (93.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Indexed trials (enrollment closed)
15 total, page 1 of 1
Study of Oliceridine (TRV130) for the Treatment of Moderate to Severe Acute Pain After Bunionectomy
NCT02815709
Study of Oliceridine (TRV130) for the Treatment of Moderate to Severe Acute Pain After Abdominoplasty
NCT02820324
A Open-label Study to Evaluate the Safety of TRV130 in Patients With Acute Pain
NCT02656875
A Pilot Study of TRV130 for the Treatment of Fracture Pain
NCT02520297
A Pharmacokinetic, Safety and Tolerability Study in Healthy Adult Males
NCT02411500
A Study of TRV130 for the Treatment of Pain After Abdominoplasty
NCT02335294
Study of the Effects of TRV130, at Therapeutic and Supra Therapeutic Doses, on QTc Intervals
NCT02344303
A Safety, Tolerability, PD and PK Study in Healthy Adults
NCT02211625
A Study to Investigate the Metabolism and Excretion of [14C]-TRV130 in Healthy Male Subjects
NCT02169934
A Study of TRV130 for the Treatment of Pain After Bunionectomy
NCT02100748
A Study to Explore the Efficacy of TRV027 in Patients Hospitalized for Acute Decompensated Heart Failure
NCT01966601
Pharmacokinetics and Pharmacodynamics of TRV130, Morphine, and Placebo in Healthy Subjects
NCT02083315
Single Ascending Dose Study of Intravenous TRV130A in Healthy Adult Males
NCT01514578
Study to Evaluate TRV120027 on Renal Pharmacodynamics in Patients With Heart Failure and Renal Dysfunction
NCT01444872
Study to Evaluate the Effects of TRV120027 in Patients With Heart Failure
NCT01187836
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 8 |
| Phase 2 | 4 |
| Phase 3 | 3 |
Therapeutic Areas
How the Trevena early-phase archive is shaped
15 indexed studies, none listed as recruiting (0% open); 14 completed (93%).
Phase mix: 3 late (III/IV) vs 12 early (I/II) (early-phase heavy).
Top condition: Kidney Disease (1 trial), 5 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Trevena: archived-pipeline peers nationwide
Peers matched on 15 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Trevena sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 15 archived trials
- Allakos · 15 trials · 0% recruiting
- Arbor Research Collaborative for Health · 15 trials · 33% recruiting
- Arena Pharmaceuticals · 15 trials · 0% recruiting
- Arrowhead Pharmaceuticals · 15 trials · 20% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Trevena page
15 registered trials is a research-attention snapshot, not an endorsement of Trevena or any single study.
- None of Trevena's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Kidney Disease is the condition Trevena studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Kidney Disease trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Trevena pipeline card: 15 registered trials from official public datasets.Report a data error.